GL1X · GenesisL1 explorer

UniProt D9IEJ2

Spike glycoprotein,Fibritin (D9IEJ2)

Spike glycoprotein,Fibritin (UniProt D9IEJ2): 24 experimental structures on GenesisL1, 1 ligand bound, 104 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
D9IEJ2
Protein
Spike glycoprotein,Fibritin
Experimental structures
24
Predicted models
0
Ligands
1
Pockets
104 · 5 records with a druggable one

Structures

24 records of D9IEJ2 in the MolNFT archive: 24 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
4NCUFoldon domain wild typex-ray diffractionA——
4NCUFoldon domain wild typex-ray diffractionA——
4NCVFoldon domain wild type N-conjugatex-ray diffractionA, B, C——
4NCVFoldon domain wild type N-conjugatex-ray diffractionA, B, C——
4NCWfoldon domain wild type C-conjugatex-ray diffractionA, B, C——
4NCWFoldon domain wild type C-conjugatex-ray diffractionA, B, C——
4ZYPCrystal Structure of Motavizumab and Quaternary-Specific RSV-Neutralizing Human Antibody AM14 in…x-ray diffractionA, B, C——
4ZYPCrystal structure of motavizumab and quaternary-specific rsv- neutralizing human antibody AM14 in…x-ray diffractionA, B, C——
5C0RCrystal structure of a generation 3 influenza hemagglutinin stabilized stem complexed with the…x-ray diffractionA——
5C0SCrystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the…x-ray diffractionA—4 (best 0.41)
5C0SCrystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the…x-ray diffractionA——
6CRVSARS Spike Glycoprotein, Stabilized variant, C3 symmetryelectron microscopyA, B, CNAG20 (best 0.89)
6CRVSARS spike glycoprotein, stabilized variant, C3 symmetryelectron microscopyA, B, CNAG—
6CRWSARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformationelectron microscopyA, B, CNAG20 (best 0.87)
6CRWSARS spike glycoprotein, stabilized variant, single upwards S1 ctd conformationelectron microscopyA, B, CNAG—
6CRXSARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformationelectron microscopyB, C, ANAG20 (best 0.87)
6CRXSARS spike glycoprotein, stabilized variant, two S1 ctds in the upwards conformationelectron microscopyB, C, ANAG—
6CRZSARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetryelectron microscopyA, B, CNAG20 (best 0.87)
6CRZSARS spike glycoprotein, trypsin-cleaved, stabilized variant, C3 symmetryelectron microscopyA, B, CNAG—
6CS0SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformationelectron microscopyA, B, CNAG20 (best 0.87)
6CS0SARS spike glycoprotein, trypsin-cleaved, stabilized variant, one S1 ctd in an upwards conformationelectron microscopyA, B, CNAG—
6CS1SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformationelectron microscopyB, C, ANAG—
6CS1SARS spike glycoprotein, trypsin-cleaved, stabilized variant, two S1 ctds in an upwards conformationelectron microscopyB, C, ANAG—
6CS2SARS spike glycoprotein - human ACE2 complex, stabilized variant, all ACE2-bound particleselectron microscopyA, B, CNAG—

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 13 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.